Alerts will be sent to your verified email
Verify Email
NGLFINE
|
NGL Fine-Chem
|
Hikal
|
Sequent Scientific
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
API Sector
|
|||
|
Total reactor capacity
|
308.0 kL | n/a | n/a |
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.94 % | 4.0 % | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
20.08 % | 12.04 % | 3.75 % |
|
5yr average Equity Multiplier
|
1.43 | 2.23 | 2.1 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 0.84 | 0.87 |
|
5yr Avg Net Profit Margin
|
12.69 % | 6.39 % | 2.4 % |
|
Price to Book
|
6.74 | 3.26 | 4.84 |
|
P/E
|
42.45 | 52.1 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
67.77 Days | 44.89 Days | 61.25 Days |
|
Inventory Days
|
51.05 Days | 66.84 Days | 70.72 Days |
|
Days Receivable
|
85.22 Days | 79.34 Days | 84.11 Days |
|
Days Payable
|
73.98 Days | 84.24 Days | 118.6 Days |
|
5yr Average Interest Coverage Ratio
|
21.07 | 4.97 | 2.9 |
|
5yr Avg ROCE
|
27.12 % | 15.64 % | 9.0 % |
|
5yr Avg Operating Profit Margin
|
22.47 % | 17.42 % | 10.83 % |
|
5 yr average Debt to Equity
|
0.2 | 0.72 | 0.46 |
|
5yr CAGR Net Profit
|
0.28 % | -5.33 % | n/a |
|
5yr Average Return on Assets
|
14.23 % | 5.39 % | 1.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.74 % | 68.85 % | 52.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.07 % | 0.08 % | -1.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.58 % | 2.48 % |
|
NGL Fine-Chem
|
Hikal
|
Sequent Scientific
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
